| NAME |
GLIMEPIRIDE 2MG/ROSIGLITAZONE MALEATE 8MG TAB |
| VA GENERIC NAME |
GLIMEPIRIDE/ROSIGLITAZONE |
| DOSAGE FORM |
TAB |
| FDA MED GUIDE |
Glimepiride-Rosiglitazone_(Avandaryl)_(2015).pdf |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| INACTIVATION DATE |
2016-01-26 00:00:00 |
| NATIONAL FORMULARY NAME |
GLIMEPIRIDE/ROSIGLITAZONE TAB |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
1x Possible Dosage |
| PACKAGE |
Both Inpatient and Outpatient |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
GLIMEPIRIDE 2MG/ROSIGLITAZONE 8MG TAB |
| VA PRODUCT IDENTIFIER |
G0407 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
TAB |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4033166 |
| EFFECTIVE DATE/TIME |
-
- 2014-03-18 00:00:00
- STATUS: ACTIVE
|
